MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-20-3715

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2021

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.

Steele Nina G, Biffi Giulia, Kemp Samantha B, Zhang Yaqing, Drouillard Donovan, Syu LiJyun, Hao Yuan, Oni Tobiloba E, Brosnan Erin, Elyada Ela, Doshi Abhishek, Hansma Christa, Espinoza Carlos, Abbas Ahmed, The Stephanie, Irizarry-Negron Valerie, Halbrook Christopher J, Franks Nicole E, Hoffman Megan T, Brown Kristee, Carpenter Eileen S, Nwosu Zeribe C, Johnson Craig, Lima Fatima, Anderson Michelle A, Park Youngkyu, Crawford Howard C, Lyssiotis Costas A, Frankel Timothy L, Rao Arvind, Bednar Filip, Dlugosz Andrzej A, Preall Jonathan B, Tuveson David A, Allen Benjamin L, Pasca di Magliano Marina

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease characterized by an extensive fibroinflammatory stroma, which includes abundant cancer-associated fibroblast (CAF) populations. PDAC CAFs are heterogeneous, but the nature of this heterogeneity is incompletely understood. The Hedgehog pathway functions in PDAC in a paracrine manner, with ligands secreted by cancer cells signaling to stromal cells in the microenvironment. Previous reports investigating the role of Hedgehog signaling in PDAC have been contradictory, with Hedgehog signaling alternately proposed to promote or restrict tumor growth. In light of the newly discovered CAF heterogeneity, we investigated how Hedgehog pathway inhibition reprograms the PDAC microenvironment.

EXPERIMENTAL

DESIGN

We used a combination of pharmacologic inhibition, gain- and loss-of-function genetic experiments, cytometry by time-of-flight, and single-cell RNA sequencing to study the roles of Hedgehog signaling in PDAC.

RESULTS

We found that Hedgehog signaling is uniquely activated in fibroblasts and differentially elevated in myofibroblastic CAFs (myCAF) compared with inflammatory CAFs (iCAF). Sonic Hedgehog overexpression promotes tumor growth, while Hedgehog pathway inhibition with the smoothened antagonist, LDE225, impairs tumor growth. Furthermore, Hedgehog pathway inhibition reduces myCAF numbers and increases iCAF numbers, which correlates with a decrease in cytotoxic T cells and an expansion in regulatory T cells, consistent with increased immunosuppression.

CONCLUSIONS

Hedgehog pathway inhibition alters fibroblast composition and immune infiltration in the pancreatic cancer microenvironment.

Для цитирования: Steele Nina G, Biffi Giulia, Kemp Samantha B, Zhang Yaqing, Drouillard Donovan, Syu LiJyun, Hao Yuan, Oni Tobiloba E, Brosnan Erin, Elyada Ela, Doshi Abhishek, Hansma Christa, Espinoza Carlos, Abbas Ahmed, The Stephanie, Irizarry-Negron Valerie, Halbrook Christopher J, Franks Nicole E, Hoffman Megan T, Brown Kristee, Carpenter Eileen S, Nwosu Zeribe C, Johnson Craig, Lima Fatima, Anderson Michelle A, Park Youngkyu, Crawford Howard C, Lyssiotis Costas A, Frankel Timothy L, Rao Arvind, Bednar Filip, Dlugosz Andrzej A, Preall Jonathan B, Tuveson David A, Allen Benjamin L, Pasca di Magliano Marina. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021. DOI: 10.1158/1078-0432.ccr-20-3715.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.